Results
1531
Companies with a Future performance score of at least 3, ordered by Future performance score.
1,531 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
DCOM | US$30.34 | -0.4% | 73.4% | US$1.4b | US$41.00 | PB1x | E71.6% | 3.3% | Banks | ||
SQM | US$37.31 | -6.1% | -22.5% | US$11.0b | US$53.57 | PS2.2x | E47.6% | 5.7% | Materials | ||
DDL | US$3.08 | -12.3% | 135.1% | US$758.4m | US$3.20 | PE24.6x | E40.7% | n/a | Consumer Retailing | ||
AMSC | US$20.01 | -16.5% | 39.4% | US$896.1m | US$39.00 | PE243x | E58.7% | n/a | Capital Goods | ||
ARR | US$18.65 | -0.5% | -3.5% | US$1.5b | US$20.00 | PS36.3x | E78.9% | 15.4% | Diversified Financials | ||
FXNC | US$24.28 | -2.3% | 35.6% | US$220.1m | US$27.00 | PB1.3x | E46.0% | 2.6% | Banks | ||
ULCC | US$6.93 | -9.9% | -9.4% | US$1.6b | US$9.90 | PE18.7x | E37.6% | 0% | Transportation | ||
UNCY | US$0.52 | -8.7% | -65.1% | US$57.1m | US$5.50 | PB1.9x | E41.1% | n/a | Pharmaceuticals & Biotech | ||
BTTR | US$1.53 | -13.1% | -79.4% | US$3.0m | US$10.00 | PS0.08x | E180.8% | n/a | Food, Beverage & Tobacco | ||
BEEM | US$2.13 | -5.3% | -69.1% | US$35.2m | US$8.50 | PS0.5x | E65.9% | n/a | Capital Goods | ||
IOVA | US$4.04 | -27.2% | -76.2% | US$1.4b | US$19.62 | PS8.1x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
FIP | US$5.34 | -7.3% | 8.3% | US$665.4m | US$12.00 | PS1.8x | E110.8% | 2.2% | Transportation | ||
LAKE | US$23.13 | -1.6% | 44.7% | US$224.2m | US$28.00 | PS1.4x | E175.9% | 0.5% | Consumer Durables | ||
ASB | US$24.23 | 0.3% | 17.5% | US$4.1b | US$28.33 | PB0.9x | E53.1% | 3.8% | Banks | ||
GAMB | US$13.68 | -5.1% | 58.3% | US$498.8m | US$18.86 | PE16.5x | E21.0% | n/a | Media | ||
ARBE | US$1.71 | -17.8% | -8.2% | US$176.5m | US$4.00 | PS160.6x | E67.8% | n/a | Tech | ||
SPR | US$34.75 | 2.1% | 1.2% | US$4.1b | US$36.65 | PS0.6x | E83.4% | 0% | Capital Goods | ||
CLSK | US$7.79 | -12.5% | -52.7% | US$2.2b | US$22.75 | PE32.6x | E30.5% | n/a | Software | ||
QTWO | US$84.10 | -1.9% | 78.4% | US$5.3b | US$108.71 | PS7.3x | E137.6% | n/a | Software | ||
LLY | US$929.72 | 5.5% | 17.3% | US$826.9b | US$995.86 | PE78.9x | E21.6% | 0.6% | Pharmaceuticals & Biotech | ||
RYTM | US$52.40 | -4.1% | 24.4% | US$3.5b | US$74.82 | PS25.5x | E62.1% | n/a | Pharmaceuticals & Biotech | ||
VRTX | US$483.31 | 0.3% | 14.0% | US$123.2b | US$497.91 | PS11.3x | E29.4% | n/a | Pharmaceuticals & Biotech | ||
PESI | US$7.66 | -6.4% | -11.8% | US$145.0m | US$18.00 | PS2.1x | E110.3% | n/a | Commercial Services | ||
SEMR | US$11.14 | -29.7% | -14.3% | US$1.6b | US$18.29 | PE198.4x | E56.5% | n/a | Software |